About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Bone Disease in Older HIV-infected Adults

NCT00935935·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ruth M. Rothstein CORE Center

With

Rush University Medical Center
Merck Sharp & Dohme LLC

Age

50–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

HIV-1 infection documented by ELISA and confirmed by western blot
Treatment with antiretroviral drugs for at least 12 months
Age 50-70 years
CD4 count \> 350 cells/mm3 for at least 6 months
HIV-RNA undetectable (\< 75 copies/ml for at least 6 months)

You may not be if

Known bone disease (primary or metastatic malignancy, osteomalacia)
Treatment for bone disease (bisphosphonates, calcitonin, strontium, sodium fluoride, synthetic PTH, or high-dose vitamin D \[\> 800 IU daily\]).

The record

StatusCompleted

PhaseNo phase

Taking part101

StartedDec 2009

UpdatedAug 3, 2012

Conditions

Osteopenia Osteoporosis HIV Infection Aging HIV Infections

Where1

Ruth M Rothstein CORE Center
Chicago, Illinois, United States

Clareo Health | Study of Bone Disease in Older HIV-infected Adults